Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.4%

3 terminated/withdrawn out of 68 trials

Success Rate

91.4%

+4.9% vs industry average

Late-Stage Pipeline

29%

20 trials in Phase 3/4

Results Transparency

13%

4 of 32 completed trials have results

Key Signals

6 recruiting4 with results

Enrollment Performance

Analytics

N/A
25(49.0%)
Phase 4
13(25.5%)
Phase 3
7(13.7%)
Phase 2
6(11.8%)
51Total
N/A(25)
Phase 4(13)
Phase 3(7)
Phase 2(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (68)

Showing 20 of 68 trials
NCT06330038Phase 4Recruiting

Anesthesia and Non-small Cell Lung Cancer Recurrence

Role: collaborator

NCT05241041Not ApplicableCompleted

Effects of Positive Psychological Group Psychotherapy and Auricular Acupressure on Withdrawal Symptoms

Role: lead

NCT07198568Recruiting

Relationship Between Swallowing Dynamics and Suprahyoid Muscle Activity in Sarcopenic Dysphagia

Role: lead

NCT05221931Not ApplicableActive Not Recruiting

Drug-Coated Balloon in Patients With High Bleeding Risk

Role: collaborator

NCT07347691Recruiting

AI-Based Prediction of Atrial Fibrillation in ESUS Patients With ICM

Role: lead

NCT07306520Not ApplicableActive Not Recruiting

Effects of the Health Promotion Program on Health Literacy, Physical and Mental Health Status, and Quality of Life

Role: lead

NCT07270848Phase 4Not Yet Recruiting

Dronedarone Rhythm Intervention for Early Atrial Fibrillation

Role: lead

NCT07154784Phase 2Enrolling By Invitation

Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

Role: collaborator

NCT06963372Not ApplicableCompleted

Assessment of Health Effects of Air Purifier Interventions on Chronic Kidney Disease Patients

Role: lead

NCT06889818Recruiting

Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)

Role: collaborator

NCT05023057Not ApplicableCompleted

Multidomain Interventions Via Face-to-face and Video Communication Platforms in Mild Cognitive Impairment

Role: lead

NCT06573268Completed

Da-vinci sp Versus xi Thyroid Surgery

Role: lead

NCT02715518Not ApplicableCompleted

FFR Versus Angiography-Guided Strategy for Management of AMI With Multivessel Disease

Role: collaborator

NCT06229405Recruiting

Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data

Role: collaborator

NCT01935778Phase 3Recruiting

Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH

Role: collaborator

NCT05725044Not ApplicableCompleted

Clinical Trial to Evaluate of Efficacy and Safety of Ginsengberry Concentrate on Fatigue.

Role: collaborator

NCT05873023Not ApplicableUnknown

Chewing Gum and Cognitive Function

Role: lead

NCT05764148Not ApplicableUnknown

Effectiveness of Behavioral Activation Treatment for Schizophrenia

Role: lead

NCT05659420Not ApplicableUnknown

High Intensity Interval Training in Chronic Heart Failure

Role: lead

NCT05301868Not ApplicableUnknown

Multidomain Intervention Via a None-face-to-face Platform in Mild Cognitive Impairment

Role: lead